For Institutional Investors in the US

Daniel Lyons, PhD, CFA

Portfolio Manager | Research Analyst
Daniel Lyons, Ph.D., CFA | Janus Henderson Investors

Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors.

Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 22 years of financial industry experience.

Articles Written

Research in Action: Investing through the Ups and Downs of Biopharma Research

Research in Action: Investing through the Ups and Downs of Biopharma Research

The biopharmaceutical industry often moves to the beat of its own drummer, creating opportunities for diversification.

Century of Biotech: Capitalizing on the Biomedical Revolution

Century of Biotech: Capitalizing on the Biomedical Revolution

Remarkable advances in biomedical research are leading to rapid growth and volatility in the biotechnology sector.